ClinicalTrials.gg
Not yet recruitingNCT07925970Updated Nov 9, 2026

Cardiac Function After Aortic Coarctation Stenting

An observational study in Aortic Coarctation, sponsored by Assiut University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-09.

Sponsored by Assiut University · Observational

Updated Nov 9, 2026Newly registeredGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
80
Ages
18 Years and older
Sex
All
01

Study summary

This cross-sectional study aims to evaluate left ventricular and left atrial strain parameters in patients at least one year after aortic coarctation stenting compared with healthy controls.

Read the detailed description

Coarctation of the aorta is a congenital heart disease that can cause chronic pressure overload and cardiac remodeling. Speckle-tracking echocardiography allows measurement of myocardial deformation parameters such as global longitudinal strain and left atrial strain.

This observational study will assess cardiac structure and function using conventional and speckle-tracking echocardiography in patients who underwent aortic coarctation stenting at least one year earlier, and will compare the findings with age- and sex-matched healthy controls. Exercise blood pressure response will also be evaluated.

02

Conditions studied

  • Aortic Coarctation

Browse trials for

Keywords

  • Aortic coarctation
  • Stenting
  • Global longitudinal strain
  • Left atrial strain
  • Assiut
03

In context

Aortic Coarctation

49 studies on the registry are indexed under Aortic Coarctation; 16 are open to participants now.

This study's planned enrollment of 80 is below the median of 100 across 29 observational studies indexed under Aortic Coarctation.

Browse Aortic Coarctation studies →

Lead sponsor

Assiut University is the lead sponsor of 5,078 studies on the registry; 2,178 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Patients who underwent aortic coarctation stenting at least one year earlier and age-, sex-, and body-weight-matched healthy controls at Assiut University Heart Hospital.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • - Patients with native or post-surgical recoarctation who underwent coarctation stenting one year or more earlier
  • Healthy controls matched for age, sex, and body weight
  • Written

Exclusion criteria

Exclusion Criteria:

  • - Refusal to participate
  • Systemic disease affecting cardiac mechanics (diabetes, collagen diseases, significant valvular heart disease, ischemia)
  • Associated congenital heart disease affecting cardiac mechanics (significant ASD, VSD, or PDA)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Post-Stenting Patients

    Patients who underwent aortic coarctation stenting at least one year earlier.

  • Healthy Controls

    Age-, sex-, and body-weight-matched healthy individuals.

06

What researchers measure

Primary outcomes

  1. Left ventricular global longitudinal strain

    Mean left ventricular global longitudinal strain measured by speckle-tracking echocardiography (percentage, more negative values indicate better systolic function).

    Time frame: Baseline

Secondary outcomes

  1. Left atrial reservoir strain

    Mean left atrial reservoir strain measured by speckle-tracking echocardiography (percentage).

    Time frame: Baseline

  2. Left ventricular ejection fraction

    Mean left ventricular ejection fraction measured by echocardiography (percentage).

    Time frame: Baseline

  3. Number of patients with exercise-induced hypertension

    Number of patients who develop exercise-induced hypertension defined as peak exercise systolic blood pressure ≥190 mmHg in females or ≥210 mmHg in males, or a rise ≥50 mmHg from baseline.

    Time frame: Baseline

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 9, 2026
Show all 1 update
  1. Nov 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07925970
Lead sponsor
Assiut University
Responsible party
Manar Ahmed Galal Mohammed (Resident Physician, Department of Cardiovascular Medicine, Assiut University) — Principal investigator
First posted
Nov 9, 2026
Start date
Nov 10, 2026 (estimated)
Primary completion
Nov 10, 2027 (estimated)
Completion
Feb 1, 2028 (estimated)
Last update
Nov 9, 2026

Study contacts

Manar A Galal, Resident
Contact
Manar.18323505@med.aun.edu.eg
01023495866
Mohamed A Karim, prof
study chair · Cardiovascular Medicine Department, Assiut University Hospitals

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion